The Blavatnik Family Foundation, whose historic gift in 2016 helped create what has become Yale’s flagship life science accelerator, has made an additional $40 million donation that will increase the number of research awards available to Yale scientists, support a wider range of biomedical innovations, and reach deeper into the Yale community to support new and innovative research.
![Dr. Akiko Iwasaki Ph.D. and Dr. Anna Marie Pyle, Ph.D. receiving an award, presented by Dean Nancy Brown, Ph.D.](/sites/default/files/styles/post_image_auto/public/2023/images/YFIA-5669.jpg?itok=yRfvSGYa)
Run by Yale Ventures, a campus-wide initiative that supports innovation at Yale, the Blavatnik Fund for Innovation at Yale creates a bridge between early-stage, innovative research and the development of high-impact biomedical products and health technologies through the support of start-ups and industry partnerships.
Areas of focus include oncology, infectious disease, neurology, immunology, digital health, ophthalmology, metabolic disease, rare diseases, platform technologies, and biological tools.